Over the last 20 years, we have invested in high-quality and advanced infrastructure across our facilities in India and the United States. We currently operate six facilities, of which five are in India and one is in the west coast of the US. Co-location of R&D laboratories and manufacturing facilities ensures a seamless technology transfer from feasibility to commercial supply.
| S. No | Location | Area(1)(sq. ft.) | Land (acres) | Type of Campus | Certifications/ Accreditations |
|---|---|---|---|---|---|
| 1. | Nacharam, Telangana, India | 183,670 | 15.9 | Discovery R&D | AAALAC(2) |
| 264,056 | Manufacturing | USFDA, EDQM, PMDA, WHO, CDSCO, ISO | |||
| 2. | Mallapur, Telangana, India | 360,108 | 15.8 | Discovery R&D, Formulations Pilot plant | CDSCO, USFDA, NABL for analytical |
| 3. | Bengaluru, Karnataka, India | 190,000 | 8 | Discovery R&D | AAALAC(3) |
| 4. | Pune, Maharashtra, India | 50,773 | 5.0 | Discovery GLP Safety Assessment | GLP, AAALAC(3) |
| 5. | Visakhapatnam, Andhra Pradesh, India(4) | 220,950 | 10.3 | Manufacturing | MFDS, DCA, CDSCO, ISO, WHO |
| 6. | Morgan Hill, California, USA(5) | 48,663 | 3.5 | Discovery Biologics R&D | AAALAC(2) |
Notes:
(1)Includes area of existing buildings.
(2)The AAALAC accreditation has been obtained for our biology animal unit located in Nacharam, Telangana and Morgan Hill, California
(3) AAALAC accredited
(4)Facility situated on a Special Economic Zone and held on leasehold basis
(5)Facility held on leasehold basis
Our research facilities and systems are certified with ISO 9001:2015, ISO 14001:2015, ISO 45001: 2018 and ISO 50001: 2018 standards. Further, our analytical laboratory located at Mallapur (Hyderabad) in India is USFDA approved and is spread over 10,000 sq. ft. in area. This facility is compliant with 21 CFR Part 11 systems maintained under cGMP conditions.
